CDT Equity Inc.’s ownership amendment reports that Mark Taylor, Prospect Capital Securities Limited and Prospect Finance Limited each ceased to be beneficial owners of more than 5% of its common stock. Prospect Capital Securities Limited and Prospect Finance Limited each directly owned 25,161 shares, or 1.7%, as of September 30, 2026.
Taylor directly owned no shares but may be deemed to beneficially own 50,322 shares, or 3.4%, through his roles as sole director and sole shareholder of each company; he disclaims beneficial ownership except to the extent of his pecuniary interest. The percentages use 1,477,789 CDT shares outstanding as of September 30, 2026, and the reported share counts give effect to the 1-for-25 reverse split effected September 28, 2026.
CDT Equity Inc.'s ownership disclosure was amended to report that Craig Wigglesworth, the reporting person, directly owned 50,322 common shares, approximately 3.4% of the class, as of September 30, 2026. The percentage was based on 1,477,789 shares outstanding that day. Mr. Wigglesworth ceased to be a beneficial owner of more than 5%, making this an exit filing. The reported share count reflects the 1-for-25 reverse split effected September 28, 2026. He reported sole voting and dispositive power over 50,322 shares and disclaimed beneficial ownership except to the extent of his pecuniary interest.
CDT Equity Inc. will effect a 1-for-25 reverse stock split on September 28, 2026, at 5:00 p.m. Eastern Time. The company expects its common stock to begin trading on a split-adjusted basis at market open on September 29, 2026, under ticker CDT. After the split, outstanding common shares are expected to be approximately 1,124,515. The $0.0001 par value per share will remain unchanged, with proportional adjustments to shares issuable under equity awards, convertible securities, warrants, and equity incentive plans. No fractional shares will be issued; eligible holders will receive cash based on the fraction multiplied by the September 28 closing price per share, adjusted for the split. The company said the split is intended to ensure continued compliance with Nasdaq’s bid-price rule.
CDT Equity Inc. (CDT) entered into new financing by issuing a senior secured convertible promissory note to J.J. Astor & Co. on September 14, 2026, with a principal amount of $2,126,250, maturing March 1, 2027 and payable in twenty-four weekly installments of $88,593.75.
The company received net proceeds of $1,501,850 and issued Common Stock Purchase Warrants to the lender for 3,468,500 shares at an exercise price of $0.25 per share, exercisable immediately for five years. The note is secured by a first-priority lien on collateral of CDT Equity Inc. and its subsidiary guarantor. Subject to limitations, the lender may convert outstanding amounts into common stock at the greater of 70% of the lowest 20-day volume-weighted average price or a $0.05 floor price, which is subject to semi-annual reset. Conversion and warrant share issuances are capped by a 4.99% (optionally 9.99%) beneficial ownership limit and require stockholder approval under Nasdaq rules, with a meeting to be held if requested, but no later than October 31, 2026.
CDT Equity Inc. (CDT) reports that Craig Wigglesworth beneficially owns 1,258,042 shares of its common stock. This represented approximately 9.6% of the 13,043,866 shares outstanding as of August 31, 2026. He holds sole voting and dispositive power over all reported shares and disclaims beneficial ownership beyond his pecuniary interest.
CDT Equity Inc. (CDT) is registering 16,825,644 shares of common stock for resale by existing selling stockholders under a Form S-1, including shares issuable upon conversion of senior secured convertible notes and exercise of warrants. The company itself is not selling securities in this offering and will not receive proceeds from the resale of these shares.
The filing details multiple 2026 financing and acquisition-related transactions, notably senior secured convertible promissory notes and warrants issued to J.J. Astor & Co. and share issuances tied to acquiring an interest in Sarborg Limited. CDT Equity executed a 1-for-10 reverse stock split effective July 17, 2026, and its common stock trades on Nasdaq Capital Market under the symbol “CDT,” last reported at $0.63 on September 4, 2026.
CDT Equity is a data-driven biotech development company focusing on repositioned, clinical-stage therapeutic assets, including AZD1656 for autoimmune disorders and AZD5904 for idiopathic male infertility. The company reports substantial net losses, an accumulated deficit, going-concern uncertainty, and identified material weaknesses in internal control over financial reporting, while depending on future financings and successful clinical development to sustain operations.
CDT Equity Inc. amended its February 19, 2026 agreement to acquire a 20% equity interest in Sarborg Limited for $8,000,000, allowing $1,750,000 (or a mutually agreed amount) of that consideration to be paid in CDT common stock, subject to a 4.99% beneficial ownership limitation. CDT will apply Sarborg audit costs as credits against cash owed and pay the remaining cash consideration from its at-the-market program with minimum payments of $150,000 per month, with any balance due by May 31, 2027. On August 31, 2026, CDT issued 650,000 shares to Sarborg based on the August 28, 2026 share price as partial satisfaction of the stock component.
CDT also issued a senior secured convertible promissory note to J.J. Astor & Co. for a principal amount of $541,620, receiving $401,200 before fees and $375,002 in net proceeds, and repaid the note in full on September 4, 2026. In connection with this note, CDT issued warrants to purchase 237,000 CDT shares at an exercise price of $1.69 per share, exercisable immediately for five years; any warrant share issuance above 19.99% of current outstanding shares is subject to Nasdaq stockholder-approval requirements.
CDT Equity Inc. (CDT) has a significant shareholder group led by Mark Taylor of New Zealand, who may be deemed to beneficially own 1,258,042 shares of Common Stock through Prospect Capital Securities Ltd and Prospect Finance Ltd. These shares represented 9.6% of CDT Equity’s outstanding Common Stock as of August 31, 2026, based on 13,043,866 shares outstanding provided by the company. Prospect Capital and Prospect Finance each directly hold 629,021 shares, or 4.8% of the class. Mr. Taylor, as sole director and sole shareholder of both entities, has shared voting and dispositive power over all 1,258,042 shares and disclaims beneficial ownership except to the extent of his pecuniary interest.
CDT Equity Inc. (symbol: CDT) is the issuer of record for a Form 4 filing submitted to the SEC.
CDT Equity Inc. (symbol: CDT) is the issuer of record for a Form SCHEDULE 13D/A filing submitted to the SEC.